Tuesday, July 30, 2019

Warning letter woes: Dr Reddy#39;s expects FDA inspection of Andhra Pradesh plant by year end

Warning letter woes: Dr Reddy#39;s expects FDA inspection of Andhra Pradesh plant by year end "On the regulatory front, the API plant at Miryalaguda was given an Establishment Inspection Report (EIR) in 2017 resolving the earlier warning letter. We also received EIR for the injectable site at the Duvvada and we are awaiting for CTO VI site at Srikakulam.

from Moneycontrol Business News https://ift.tt/2Mrpt5k

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...